Two additional studies have shown activated CHEK1 in complex karyotype AML [38,39], aligning with our finding in Figure 4A that while CHEK1.pS345 is high in many patients, expression is slightly more elevated in the complex karyotype sub-groups of C3 and especially C6. This evidence concerns the gene CHEK1 and acute myeloid leukemia.